Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Safinamide Methanesulfonate
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Newron Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, Newron will sponsor the study and be responsible for Xadago (safinamide), development and execution, as well as leading on all related regulatory interactions. Newron and Zambon will evenly share the cost of the study.
Product Name : Xadago
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 12, 2021
Lead Product(s) : Safinamide Methanesulfonate
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Newron Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Riluzole
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Riluzole Orodispersible Film Replicate Bioavailability
Details : Riluzole is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 29, 2021
Lead Product(s) : Riluzole
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Voriconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects
Details : Voriconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Aspergillosis, Allergic Bronchopulmonary.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 18, 2020
Lead Product(s) : Voriconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable